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ABSTRACT 
A huge amount of genetic information is available thanks to the recent advances in sequencing 
technologies and the larger computational capabilities, but the interpretation of such genetic data 
at phenotypic level remains elusive. One of the reasons is that proteins are not acting alone, but 
are specifically interacting with other proteins and biomolecules, forming intricate interaction 
networks that are essential for the majority of cell processes and pathological conditions. Thus, 
characterizing such interaction networks is an important step in understanding how information 
flows from gene to phenotype. Indeed, structural characterization of protein-protein interactions 
at atomic resolution has many applications in biomedicine, from diagnosis and vaccine design, to 
drug discovery. However, despite the advances of experimental structural determination, the 
number of interactions for which there is available structural data is still very small. In this 
context, a complementary approach is computational modeling of protein interactions by docking, 
which is usually composed of two major phases: i) sampling of the possible binding modes 
between the interacting molecules, and ii) scoring for the identification of the correct orientations. 
In addition, prediction of interface and hot-spot residues is very useful in order to guide and 
interpret mutagenesis experiments, as well as to understand functional and mechanistic aspects 
of the interaction. Computational docking is already being applied to specific biomedical 
problems within the context of personalized medicine, for instance, helping to interpret 
pathological mutations involved in protein-protein interactions, or providing modeled structural 
data for drug discovery targeting protein-protein interactions. 
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1. Importance of protein-protein interactions in cell 
A cell is the basic structural and functional unit of any living organism. From single cell 
organisms to multicellular organisms, most of the cells have information stored in the DNA, 
coded in the form of nucleotide sequences, which must be transcribed into RNA, and then in turn 
into a chain of amino acids, the building blocks of proteins. This straightforward flux of 
information is the so-called “central dogma” Crick (1970). However, this linear view of the flow 
of information is incomplete. In nature, self-interacting elements capable of modifying the above 
described flux of information challenge the idea of the central dogma. This is the case of 
ribozymes with self-catalytic activity (Lilley & Eckstein, 2007), and prions (Derkatch & 
Liebman, 2007), misfolded proteins that can alter the structure and function of other proteins. 
These self-interacting elements add loops to the straight line in the central dogma. Even with 
these added loops, this view does not fully depict the crowded and dynamic environment inside 
the cell. There are additional genetic mechanisms that regulate the levels of proteins. An example 
of this is the field of epigenetics where the marks found in the DNA nucleosomes, such as 
methylation, prevents the transcription of DNA (Bharathy & Taneja, 2012). Proteins themselves 
appear to have an active role to protect the balance of gene products when the cell presents an 
abnormal load of the genetic material like in polyploidy Stingele et al. (2012). Among all of the 
interactions and factors that are driving all these processes, proteins have a prominent role as 
they can serve as scaffolds, provide protection to RNA or DNA (chaperones and nucleosomes), 
and act as receptors or effectors (such neuropeptides and enzymes). 
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Most proteins do not act as isolated units, and their interactions with biomolecules, 
including other proteins, are essential in the virtual totality of cellular events (Stingele et al., 
2012; Teichmann, 2002). The majority of cell processes require the assembly of protein 
complexes, which constitute the so-called quaternary structure. 
The relationship between the genetic information contained in the DNA and the structure 
of proteins is currently object of intense investigation. Recent sequencing efforts have yielded 
much information on the variants in genes (mutations), and association studies have revealed that 
these variations are tightly linked to the physiological outcome of the organism (Freedman et al., 
2011; Lander, 2011). There are two major approaches to analyze the effect of these variants: a 
reductionist view where the analysis is focused on the molecular effect of a mutation based on 
the 3D atomic structure of the protein of interest, and a systems approach focused on the effect 
on the network generated by the interactions between the elements in the cell (Figure 1). The 
synergy between these two approaches provides understanding on how variations in the genetic 
information can have effects on the phenotype ranging from an atomic level to the entire network 
organization, and for this, understanding protein-protein interactions from structural, dynamics 
and energetics points of view is essential. 
 
[INSERT FIGURE 1 HERE] 
 
2. Protein-protein interactions and human disease 
2.1. From gene to disease: Towards personalized medicine 
High-throughput techniques, like genome sequencing, mass spectroscopy and DNA and 
RNA expression microarrays, are dramatically changing the way we study biological sciences. 
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The first major change arises from the massive data generated by these techniques. Next-
generation sequencing (NGS) technologies have dramatically lowered the costs of gene 
sequencing, and are providing genomic information for an increasing number of healthy 
individuals and patient populations. A biological scientist has to face the overwhelming stream 
of information from different sources, ranging from microorganisms (Venter et al., 2004) to 
patients in health care systems (Baoying, Ruowang, & William, 2015). Computational resources 
are fundamental to efficiently analyze all this data. Institutes like National Center for 
Biotechnology (NCBI) and the European Bioinformatics Institute (EBI) receive data from 
different sources and store it in big public databases such the GenBank (Benson, Karsch-
Mizrachi, Lipman, Ostell, & Wheeler, 2005) and UniProt (UniProt, 2007).  Moreover, they have 
integrated a variety of tools like BLAST (Altschul, Gish, Miller, Myers, & Lipman, 1990) or 
CLUSTAL (Higgins & Sharp, 1988) in publicly available websites with the goal of providing the 
scientific community with analytical tools for their research. This vast amount of information is 
an opportunity for biological sciences to put statistical methods and rigorous mathematical 
models into the molecular details that rule a living organism. 
Following the first human genome completion (Human Genome Sequencing, 2004), the 
scientific community started an international effort known as the “1000 genomes project” 
(Genomes Project et al., 2015). The project, now finished, consisted in obtaining the genome 
sequence from subpopulation around the world, making the genomes available to the scientific 
community for a variety of analysis. It also provides a framework for important questions on 
human genetics. In the past, the study of the genetic variation in the human population or 
genotypes was only possible using the unique gene variants that gave rise to evident distinct 
states or phenotypes. While the term genotype refers to the information stored in the DNA 
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sequences, the term phenotype refers to the product of the genotype or “what we can see”, which 
can mean a protein fold or a cell type or even the look of the whole organism. With the lower 
costs of genome sequences and resources like the "1000 genomes", common genetic traits were 
found to be present in a large proportion of the human population (International HapMap et al., 
2010).  Many of these traits were determined by Single Nucleotide Polymorphisms (SNPs). 
SNPs are single base pair changes in the DNA sequence that occur with high frequency on the 
human genome (Genomes Project et al., 2010) and the field of human genetics now use it as the 
unit for genetic variation in populations. The International HapMap Project aims to identify 
changes among the genomes and to find correlations with the observed phenotypes. The number 
of SNPs per human genome is estimated to be around 10 million, all of them showing a different 
effect. HapMap has so far catalogued 1.6 million SNPs with genotypes from 11 human 
populations, including Japanese population from Tokyo, the Yoruba population from Africa, Han 
Chinese from Beijing, and European descent population (International HapMap et al., 2010; 
Ritchie et al., 2010; The International HapMap, 2005). 
 Genome-Wide Association Studies (GWAS) are a powerful tool to identify a link of a 
relevant SNP with a human disease (Welter et al., 2014). The goal of GWAS is to identify genetic 
risk factors through various association tests, backed by statistical analysis, to make predictions 
about who is predisposed to a given disease, and then determine the genetic interplay of disease 
susceptibility for the development of new therapeutic strategies (Bush & Moore, 2012). The 
most successful application of GWAS has been the identification of DNA sequences that play a 
role in drug response (metabolism, efficacy or adverse effect). Warfarin dosage is an obvious 
example of this success (Cooper et al., 2008). A GWAS study led to discover a set of SNPs in 
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several genes that influence warfarin dosing. This, with further validation studies, became a 
clinical genetic test, which allowed physicians to give the correct amount of warfarin to patients.  
The relationship between genetic analysis and clinical outcome fostered the field of 
personalized medicine. The current project "10K genomes" in the United Kingdom (Koepfli, 
Paten, Genome, & O'Brien, 2015) is a scientific enterprise taken by the British government for a 
personalized medicine in the public health care. The objective is to diagnose patients with rare 
diseases, who otherwise would never get proper treatment. Candidate genes detected through 
GWAS are generating large datasets of genetic variants associated with disorders, which are 
being deposited in public databases, such as Online Mendelian Inheritance in Man (OMIM) 
(Scott, Amberger, Brylawski, & McKusick, 1999), the database of Genotypes and Phenotypes 
(dbGAP) (Tryka et al., 2014) or Humsavar (UniProt, 2007). 
 
2.2. The human protein-protein interactome: A link between gene and system 
The analysis of the data obtained by high-throughput technologies also produced a revolution in 
the biological field. It marked the start of the “OMIC era” (Kandpal, Saviola, & Felton, 2009). 
Genome, Proteome, Peptidome, Exome, Transcriptome, are different ways to profile and classify 
the biological activities of the cell. However, the analysis of any of these profiles in isolation 
does not give the answer to fundamental questions about the genotype-phenotype relationship 
(Vidal, Cusick, & Barabasi, 2011). To infer the physiological effect caused by the changes in 
these profiles is necessary to study how the elements of a cell affect each other. Such “omic” 
sciences require an integrated approach to study the elements on a given condition by analyzing 
the interplay between these elements to achieve a biochemical function within the context of a 
network (Wu, Hasan, & Chen, 2014). The signaling pathways of the cell constitute a well-
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understood example of how the elements of the cell interact to elicit a molecular process. From 
an outside stimulus, receptor proteins transduce the signal using small molecules known as 
second messengers, such as the circular Adenosine Monophosphate (cAMP). Enzymes like 
kinases use the energy stored in Adenosine Triphosphate (ATP) to activate other proteins and 
start a cascade that produces the release of other second messengers, like Inositol Triphosphate 
(IP3) and calcium ions. Second messengers can be sensed by other proteins to inhibit the 
signaling or to start other pathways, in many cases reaching the nucleus and regulating the DNA 
transcription (Lemmon & Schlessinger, 2010). Pathways become interconnected networks when 
components of one pathway interact and control elements of another pathway. Graph theory can 
help to analyze a system as complex as the cell. A young discipline in biology, Systems biology, 
is taking advantage of computational approaches to understand how these interactions can have a 
response (Ma'ayan, 2009). Systems biology is the study of how molecules interact to give rise to 
subcellular machineries that form the functional units capable of performing the physiological 
functions needed for the cell, tissue or organ (Bhalla & Iyengar, 1999). The network analysis in 
systems biology intent to gain biological meaning using a global network diagram derived from 
available data (Wu, Harrison, & Chen, 2009). 
Large-scale studies at proteomic level have become widely accessible to the community 
(Chuang, Kozakov, Brenke, Comeau, & Vajda, 2008; Kuhner et al., 2009; MacBeath, 2002) and 
are generating a diverse and increasing amount of data, including protein binding and pathway 
information (Aranda et al., 2010; Ogata et al., 1999; Szklarczyk et al., 2015). This has facilitated 
the computational construction of genome-wide networks of interactions, or "interactomes" 
(Rolland et al., 2014). Thus, a system-wide approach can point out the essential elements for 
regulating a given biological process (Wu et al., 2014). For example, the response to a stimulus 
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depends on the state of the signaling networks, and this can be used in system biology to predict 
the outcome of such stimulus at molecular level (Janes et al., 2005). An interactome network 
describes the interaction of genes or gene products, which means that to provide some 
explanation of the genotype-phenotype relationships the networks have to include interactions at 
different levels. To make the predictions reliable and unbiased, the macromolecular interactions 
such as DNA-protein, post-translational modification and its target, or protein-protein 
interactions (PPI) need to be of high quality and extensive (Rolland et al., 2014). PPIs are 
probably the most critical networks as they underlie in almost all key cellular events like 
proliferation, cell signalling, regulation or cell morphology alteration (Teichmann, 2002).  
The most widely-used high-throughput laboratory techniques to construct PPI networks 
are perhaps the Yeast Two-hybrid (Y2H), and Tandem Affinity Purification coupled with Mass 
Spectrometry (TAP-MS). Y2H is an ingenious system that uses separable transcriptional factors 
and a reporter gene to prove the interaction between two proteins. The transcriptional factors 
have two separable domains, a DNA-binding domain (BD) and a transcription activation domain 
(AD). The target protein is fused with the BD and is called the bait, the binding partner is fused 
with the AD and is called the prey. The interaction between bait and prey reconstitute the 
function as a transcription factor, which can allow the expression of reporter gene downstream 
from the AD binding sequence (Fields & Song, 1989). TAP-MS relies on tags attached to the N-
terminus of target proteins. The intended target proteins are expressed inside the cell and allowed 
to interact. Then, the target protein complexes are isolated by two steps of affinity purification. 
The proteins that co-purified with the tagged proteins are identified by mass spectrometry (Puig 
et al., 2001). Complementing the initially constructed networks with text mining of the literature 
has facilitated building the interactomes of different organisms, like S. cerevisiae (Ito et al., 
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2000; Uetz & Hughes, 2000), C. elegans (S. Li et al., 2004), A. thaliana (Cui et al., 2008), D. 
melanogaster (Giot et al., 2003; Guruharsha et al., 2011) and human (Ewing et al., 2007).  
The estimated size of the human interactome ranges from 130,000 to around 650,000 
binary protein-protein interactions (Rual et al., 2005; Stumpf et al., 2008). Among them, the 
number of protein-protein interactions that are known with high confidence ranges between 
14,000 PPIs (Rolland et al., 2014) and 93,000 PPIs (Interactome3D January 2017 release; 
http://interactome3d.irbbarcelona.org/), which shows that the human interactome is far from 
being completed. The main challenge in the study of the interaction networks is to extract 
biologically relevant information from an extensive list of interactions taking into account 
different sources of the data, in order to gain insight into the molecular mechanism that drives 
various conditions (Glazko & Emmert-Streib, 2009; Khatri, Sirota, & Butte, 2012). 
Comprehensive integrative approaches that take into account data from DNA microarrays, 
protein expression, PPI information, and interaction with metabolites are added to the complexity 
in the analysis of cellular functions (Ideker et al., 2001; MacBeath, 2002). To gain knowledge 
from this vast source of information, network and pathway analysis can help to interpret the 
changes in the PPIs caused by external stimuli. The first generation of human protein interaction 
sets allowed network-based answers to the genotype-phenotype relationship, however, given 
their limited quality were not useful to make global, accurate interpretations (Rual et al., 2005; 
Stelzl et al., 2005). Network analysis used the topology of the network to highlight key nodes 
and strong interactions between different molecules, known as modules (Hartwell, Hopfield, 
Leibler, & Murray, 1999; G. Li et al., 2014). In network analysis, biological networks are 
described as “small world and scale-free” (Barabasi & Oltvai, 2004). This basically means that 
the human interactome contains several highly connected molecules, i.e. nodes that are known as 
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“hubs.” These proteins usually have a fundamental role in signaling pathways and their function 
is almost essential for the cell. The highly dynamic character of the interactions in the signaling 
pathways is a characteristic that provides robustness to the interactome (Albert, Jeong, & 
Barabasi, 2000). 
In complex networks like the human interactome, there are no clear clusters because of 
the scale-free property. The scale-free property makes biological networks similar to nonlinear 
problems like chaos, phase transitions, and fractals (Strogatz, 2001). In fact, using only 
topological information and a nonlinear dynamical modelling known as the ant colony 
optimization, revealed fractal-like patterns in protein interaction networks in yeast (Wu & Chen, 
2012), Breast Cancer (Wu, Harrison, et al., 2009), and Alzheimer disease (Wu, Huan, Pandey, 
Zhou, & Chen, 2009). 
This indicates that the complexity of the PPI networks changes in a continue manner due 
to the dynamics of the cell. On the other hand, we know that activity in a cell emerges from 
functional modules, defined as a group of different proteins that interact but that are not 
necessarily present in the same space and time (Hartwell et al., 1999; Pizzuti & Rombo, 2014). 
Thus, there must exist some degree of clustering. There are two different ways to detect 
functional modules: graph clustering, or distant-based clustering. Graph clustering takes full 
advantage of the topology itself, as it searches for groups of nodes in the network that have more 
intra-connections than inter-connections. Some graph clustering methods are Highly Connected 
Subgraph (HCS) (Hartuv & Shamir, 2000), Restricted Neighborhood Search Clustering (RNSC) 
(King, Przulj, & Jurisica, 2004) and Markov Clustering (MCL) (Enright, Van Dongen, & 
Ouzounis, 2002). In the distance-based clustering method, some metrics from graph theory 
become the similarity measure that clustering algorithms will use to identify the modules. Some 
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of these metrics are the number of edges (Vazquez, Flammini, Maritan, & Vespignani, 2003), 
shortest path (Arnau, Mars, & Marin, 2005), and shortest path profiles (Maciag et al., 2006). 
 
2.3. Interaction networks are key to understand biological pathways 
Parallel to the network analysis, pathway analysis is a simplified approach that reduces the 
complexity of interpreting all available data and increases the explanatory power. Grouping 
proteins, genes, and PPIs according to the biological process where they participate can reveal 
clustering for a given event. This categorization breaks down long lists into smaller subsets that 
can be used to identify differences between two conditions, thus increasing the explanatory 
power (Glazko & Emmert-Streib, 2009; Khatri et al., 2012). Pathway analysis is different from 
the network analysis, because it uses functional information about the proteins, like cellular 
localization, catalytic activity, and processing aspects. Pathway analysis is more successful when 
it includes PPIs networks, Gene Ontology terms (GO) and expression data. The assumption that 
proteins in the same pathway and with common functions are tightly regulated can lead to the 
discovery of the “pathway network module”. In this way, we can delimit a large set of proteins 
that co-regulate each other to perform a particular cellular function (Wu et al., 2014). 
Additionally, in some biological networks, there is a correlation between GO terms and node 
distance (Y. R. Cho, Hwang, Ramanathan, & Zhang, 2007; Lord, Stevens, Brass, & Goble, 2003; 
Sevilla et al., 2005). On the downside, the annotation of a GO term has a heterogeneous origin, 
based on a variety of experiments and computational methods, which often leads to 
inaccurate/contradictory annotations and interpretation problems due the functional diversity of 
the proteins under different conditions (Luciani & Bazzoni, 2012). 
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There are different databases for protein networks and biological pathways: Biogrid 
(Chatr-Aryamontri et al., 2017), Reactome (Croft et al., 2011),  KEGG (Qiu, 2013), STRING 
(von Mering et al., 2003), PAGED (H. Huang et al., 2012), HPD (Chowbina et al., 2009), 
BioCarta (Nishimura, 2001), or Interactome3D (Mosca, Ceol, & Aloy, 2013). Many of these 
databases provide, in addition to the list of interactions, information like the effect of the 
interaction (inhibition or activation), or the location of the interaction (e.g., nucleus, cytoplasm, 
and so forth). On the other hand, a number of databases provide experimentally obtained 
structures of PPIs but lack the integrating context of the networks: 3D interologs (Lo, Chen, & 
Yang, 2010), 3D complex (Levy, Pereira-Leal, Chothia, & Teichmann, 2006), SCOPPI (Winter, 
Henschel, Kim, & Schroeder, 2006), IBIS (Shoemaker et al., 2012), 3did (Mosca, Ceol, Stein, 
Olivella, & Aloy, 2014), PIFACE (Cukuroglu, Gursoy, Nussinov, & Keskin, 2014). Interestingly, 
STRING and Interactome3D provide the 3D structures of the proteins and the complexes they 
form, in the context of network data.  
 
2.4. Disease-related interaction networks 
Smaller subsets of the human interactome can be used to find answers to the genotype-phenotype 
relationship. Combining GWAS data, technically a “cause-effect” list for genes, with the network 
view has provided the most comprehensive data for complex diseases. As complex diseases are 
caused by several genes (e.g., heart disease, cancer, and diabetes), the use of networks seems a 
natural approach to gain insight on their molecular basis. The human diseasome, which links 
phenotypic features to all known disease genes, is the result of that approach (Goh et al., 2007). 
The human diseasome can be exemplified by a bipartite graph in which a set of disease nodes is 
linked with disease gene nodes (Goh & Choi, 2012). The objective of the construction of a 
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network for each complex disease holds the promise of identifying those interactions altered by 
mutations, which could help to find a treatment to revert the network back to normal state. The 
core of the human diseasome can be identified using a set of PPIs that are affected by a mutation 
leading to a pathological state. It can be obtained by purely computational tools and can help to 
highlight the key players that drive most of the characterized diseases (Janjic & Przulj, 2012). 
Even if the main disease-related proteins are identified, these advances do not mean a way to 
find a magic bullet for all pathologies. The highly dynamic nature of the signaling pathways due 
to their inter-connectivity is a characteristic that adds robustness to the cell (Kitano, 2004a). One 
example of a robust disease is cancer. A cancer tumor is a population of different cell types, each 
harboring their own mutations (Calon et al., 2012; Ding et al., 2012; Gerlinger et al., 2012; Hou 
et al., 2012). In this way, there are intracellular and intercellular interaction networks with 
different dynamics, since not all the proteome is expressed sequentially in a specific cue (S. P. 
Shah et al., 2012). Given the finite number of interactions between nodes in the cellular 
networks, there is a limit to the number of network configurations or states they can adopt. By 
rewiring the connections of a signaling network, cancer mutations are probably creating new 
states that are only present in cancer cells, and that are known as cancer network attractors states 
(Creixell, Schoof, Erler, & Linding, 2012). 
The inter-connectivity of signaling pathways or pathway crosstalk is the underlying 
reason for such high network dynamics and is one of the reasons why a drug specifically 
designed for a key protein in a disease can fail. Thus, when a key pathway is inhibited, the cell 
may use another pathway that can have a similar physiological effect. The multiple layers of 
gene regulatory interactions modified by the alteration of the genetic material and structure (e.g. 
mutations in DNA, or aneuploidy at chromosomal level) combined with feedback loops give rise 
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to the robustness of the cancer cell. Thus, ‘de novo’ mutations during chemotherapy, in 
combination with feedback controls, allow the cancer cell to be resistant to treatment (Kitano, 
2004b). 
This is a problem from a pharmaceutical point of view, since a designed drug will be 
labeled as useless when it fails to stop the disease progression. Traditionally, the pharmacological 
approach to treat a disease has been a reductionist one, i.e. “one disease - one target - one drug”. 
In recent years, this has caused two major problems in the pharmaceutical field: 1) “me-too” 
drugs, when many companies design drugs for the same targets, and 2) poor assignment of 
medication to phenotypes due to multi-target properties (Frail & Barratt, 2012). The combination 
of systems biology with drug discovery, known as network pharmacology, is starting to change 
the approach of “one disease - one target - one drug” (Brown & Okuno, 2012). The generation of 
diseasome networks does not aim exclusively to determine the role of the gene or protein. We 
can add information such as the mutations that cause a given disease or confer susceptibility to a 
drug, in order to determine the role of individual players in the crosstalk context. A recent study 
showed that by using the pathway crosstalk data and available approved drugs it is possible to 
combine certain drugs targeting a particular signaling pathway in order to reduce the dose, while 
still being effective against cancer. As a consequence, this strategy has helped to develop an 
effective treatment less harmful to the patient (Jaeger & Aloy, 2012; Jaeger, Duran-Frigola, & 
Aloy, 2015). 
Progress made with these different approaches has improved the rational design of drugs. 
Most of the designed drugs aim to block the binding sites of a protein. If the expected target of a 
drug is an enzyme, a first approach is to block the catalytic binding site, as in the case of 
neuraminidase inhibitors (Russell et al., 2006; Vavricka et al., 2011). An alternative approach to 
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target protein activity is by interfering protein interaction binding sites, therefore stabilizing or 
disrupting PPIs, like the transthyretin inhibitors (Sant'Anna et al., 2016).  In fact, some mutations 
are lethal by modifying or interfering in a protein binding site, as in the case of the formation of 
amyloid fibrils that precedes the Amielod Lateral Sclerosis or Alzheimer's disease. In these cases, 
a mutation in the protein transthyretin destabilizes the formation of the normal multimer protein 
state, causing the proteins to aggregate in the form of fibrils. In this way, the mechanistic detail 
of how the protein is affected by drugs or mutations can only be given by the 3D structure of the 
protein and the complexes that it forms. Therefore, a high-quality image of the 3D structure of 
the proteins and the complexes they can form is an essential requirement for the design of 
effective drugs, which combined with the network approach, gives rise to new pharmacological 
strategies to treat disease in humans.  
 
3. Structural approach to protein-protein interactions  
Several diseases such as cancer or RASopaties (a group of diseases related to the 
malfunction of Ras signaling pathway), display altered PPIs networks (Kiel & Serrano, 2014). 
Current therapies that only target a single protein are not efficient in restoring the phenotype to 
normal in intricate signaling pathways. It would be needed to use a network-based therapeutic 
strategy to turn back the appearance of a malignant attractor state in the signaling network (Vidal 
et al., 2011). The use of pathway analysis on the network of interest could help to force the 
regression to the normal state. Current network maps give information on the relationships of 
genes or interactions between proteins (Figure 2). However, the vast majority of network 
analyses is done at a level of resolution that makes it difficult to include the three-dimensional 
(3D) structure of the cellular components at atomic level, a fundamental aspect that should be 
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taken into account (Kiel, Beltrao, & Serrano, 2008). From the amino acid sequence (primary 
structure), the inherent physicochemical properties of the polypeptide chain determine the first 
level of folding, known as secondary structure, with elements such as β-sheets or α-helices, as 
well as loops that do not fold into a specific structure. From this, combinations of β -sheets and 
α-helices can form the tertiary structure, where many proteins gain their functionality. The 
assembly of different polypeptide chains in complexes forms the quaternary structure. Databases 
such as STRING (von Mering et al., 2003) and Interactome3D (Mosca et al., 2013) provide 
curated information about the 3D structure of known protein-protein complexes. This type of 
information is of paramount importance for the understanding of biological processes at 
molecular level, as well as for applications in biomedicine such as rational drug design or 
repurposing studies, or interpretation of pathological mutations. Below are described the major 
experimental approaches to characterizing the structural details of protein-protein interactions. 
 
[INSERT FIGURE 2 HERE] 
 
3.1. X-ray Crystallography 
The most widely used and accurate approach for obtaining high-resolution protein structures is 
the crystallography of proteins in combination with X-ray diffraction. A highly concentrated 
purified protein is needed for crystallization. Exposure of the crystal to an x-ray beam provides a 
diffraction spot pattern that gives information about “structures factors”, which allows building a 
map of electron density. The mathematical process to convert the intensities of the diffraction 
spots to the electron map is known as the phase resolution problem. The goal is to build a model 
of the protein based on this map, in which the protein sequence is the input to produce a 
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thermodynamically stable structure (Smyth & Martin, 2000). However, the process is very slow, 
requires a large amount of sample at a high purity quality, and often the protein has to be 
modified to achieve crystallization, with the risk of modifying the natural folding of the protein. 
Obtaining a crystal is not a routine process, since the conditions to find the formation of a crystal 
vary from sample to sample. Even after successfully obtaining a crystal, it might not be 
sufficiently optimal to determine the structure with high definition. Moreover, factors like the 
temperature and pH can affect the folding of the protein so that different structures can be 
obtained (Schiffer et al., 1989). In fact, there are cases where the applicability of this technique is 
extremely hard or unfeasible. Membrane proteins and low affinity complexes fall in this 
categorization since obtaining a crystal requires the stabilization by the membrane bilayer or a 
chemical scaffold to maintain the proteins folded and in close contact altering their natural 
conformation. Also, intrinsically disordered proteins, or very flexible loops present a problem 
since the periodicity required in for solving the phase problem cannot be easily achieved. 
Additionally, in some cases the use of a crystal structure as the representation of the biological 
relevant conformation of the protein in vivo has been challenged and is still under debate 
(Bahadur, Chakrabarti, Rodier, & Janin, 2004; Bahadur, Zacharias, & Janin, 2008; Ofran & Rost, 
2007). 
 
3.2. Nuclear Magnetic Resonance (NMR) 
Another widely used technique to elucidate the 3D structure of a protein is Nuclear Magnetic 
Resonance (NMR). Since the 50’s NMR has evolved from the field of physics to the medical 
application. NMR relies on the use of strong magnetic fields where the nuclei and electrons of 
the atoms absorb the electromagnetic energy and reach a frequency of emission similar to the 
PROTEIN-PROTEIN DOCKING IN BIOMEDICINE 20 
natural isotopes (typically C13 and H1). However, this signal changes due the surrounding 
environment, thus giving also information of the nearby atoms. The advantage of NMR over the 
crystallography is that protein is in solution, a more natural environment that allows small 
movement of the proteins. It is very useful for determining the motions of proteins, including 
those large portions that do not have specific folding and are called intrinsically disordered. 
NMR experiments are time consuming and expensive, since larger molecules need machines 
with higher and higher frequency magnets. Thus, a major drawback of NMR is the size of the 
sample, since currently structures larger than 35 kDa cannot be determined. Therefore, in 
comparison with X-ray crystallography, very few complete structures of PPIs have been obtained 
by NMR, being especially difficult the case of multi complexes (Marion, 2013; N. Shah, Sattar, 
Benanti, Hollander, & Cheuck, 2006). 
 
3.3. Cryogenic Electron Microscopy (Cryo-EM) 
This technique is based on Electron Microscopy (EM). Standard EM needs to coat the sample 
with some special protector that usually contains metal particles like silver or gold, generating a 
layer with valleys and mountains according to the shape of the sample. Then, a laser is applied to 
the surface produced in the layer, creating the image in slices as it passes like in confocal 
microscopy. However, to enhance the image of minuscule samples, and to prevent degradation, 
and motion, the sample is fixed on a plate at very low temperatures, which is the basis for Cryo-
EM. 
Until recently Cryo-EM was regarded as a low-resolution technique because it presented 
a barrier at 6 Å of resolution and only allowed the inference of huge structures. However, with 
the recent improvement of the sensors, and high-level algorithms for image recognition, the 
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reconstruction of the 3D structure up to 2 Å resolution is possible (Elmlund & Elmlund, 2015). 
Still, many of the structures determined by this method are low-resolution and do not reveal the 
atomic details needed for most biological applications.  
 
3.4. Small angle X-ray scattering 
A recent structure determination development is the small angle X-ray scattering (SAXS). In 
contrast to crystallography, in SAXS the sample is exposed to an X-ray beam of a particular 
wavelength that is moved from 0 to 5 degrees to produce intensity distributions. The generated 
profile contains structural information of the atoms in the protein that can be in three different 
regions: the Guinier region that can be related to the average size of the group of atoms, the 
Fourier regions that contain information about the shape of the atoms in the protein, and the 
Porod region that provides information about the surface occupied in the volume by the atoms 
(Boldon, Laliberte, & Liu, 2015).  The advantage of this method is that proteins can be studied in 
different media and even disordered. Interestingly, for the resolution of protein complexes, this 
technique can be coupled with other computational methods such as molecular dynamics or 
protein docking algorithms (Jimenez-Garcia, Pons, Svergun, Bernado, & Fernandez-Recio, 
2015). 
 
4. Computational modeling of protein-protein interactions 
Despite all the recent advances, the majority of protein complexes are yet to be resolved. 
While there are 3D structures for nearly 50% of the proteins forming the human proteome 
(Muller, MacCallum, & Sternberg, 2002), only a small fraction (<7%) of the complexes forming 
the known human interactome are structurally characterized (Mosca et al., 2013). Thus, an option 
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to fill the structural gap in the human interactome is the use of computational modeling. The first 
attempt would be to construct the 3D structure of a complex from the amino acid sequence based 
on the available structure of complexes formed by similar proteins, using ab initio or homology-
based modeling techniques similar to those used to model individual proteins. In this sense, the 
CASP experiment (Critical Assessment of Techniques for Protein Structure Prediction) 
(Kryshtafovych, Fidelis, & Moult, 2014) aims to assess how accurate is the prediction of current 
modeling programs in blind conditions. One approach is to make fully ab initio predictions from 
the protein sequences, considering the physicochemical properties of the amino acid and the 
energy terms that drive the folding. An alternative approach is to take advantage of the structures 
deposited in the PDB, by comparing gene products of different genes but with similar folding, 
so-called homology modeling. Homology modeling is a powerful tool to determine the 3D 
structure of proteins and complexes with a high degree of similarity. The most successful 
programs in CASP are multithreading software able to use structures deposited in the PDB, 
sequence similarity, and a little ab initio modeling. Winning strategies in the last editions of 
CASP are those of I-Tasser (Y. Zhang, 2008) and QUARK (Y. Zhang, 2014) which are programs 
that integrate fragment search in the PDB with the identification of basic folds that can be used 
as templates, and then fragments can be assembled  into models of proteins.  
 
4.1. Protein-protein docking 
As above described, experimental determination of the structure of a PPI is highly challenging. 
Co-crystallizing two proteins is much more challenging than finding the right conditions for an 
individual protein; NMR has a size limitation, which leaves out mesoscopic protein ensembles, 
and Cryo-EM is still in development. As a consequence, all these experimental procedures can be 
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defined as low-throughput. These limitations create a gap between the number of new PPIs that 
are being discovered with high throughput experiments, and the very few 3D complex structures 
that are being determined. Computational approaches aim to compensate the difficulties in the 
determination of PPIs structures. However, predicting the 3D structure of the complex formed by 
two interacting proteins is a very challenging problem. The issue is similar to the structural 
prediction in individual structures, in the sense that both cases need a description of the 
physicochemical forces that regulate the interactions between the amino acid residues. Features 
such amino acid complementarity, electrostatics, steric clashes, hydrophobic effect, or hydrogen 
bonding, are concepts shared between both problems.  
Unlike the problem of protein folding where the degrees of freedom in which a protein 
sequence can fold makes the space of search extremely large, in complex structure prediction, 
proteins are assumed to have 3D structure. This means that the search space is a six degree 
problem (three translations and three rotations), if we do not consider internal movements (rigid-
body search). Computational tools such as protein-protein docking try to predict ab initio the 
correct orientation of two proteins that interact. Two major technical aspects can be found in the 
majority of docking methods: the generation of a large variety of structural models (sampling) 
and the identification of the correct docking poses with a proper function (scoring) (S. Y. Huang, 
2014) (Figure 3). At the core of several docking protocols resides the idea of geometric 
complementarity in the protein-protein interface. However, in recent years different mechanisms 
have been proposed for protein-protein association: i) A basic mechanism called “lock and key”, 
directly inspired in complementarity, where the unbound monomers have a matching symmetry 
that is energetically favorable for the complex formation. This binding mechanism implies that 
both monomers are rigid, and they fit into one another; ii) The "induced fit" mechanism involves 
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conformational changes after binding of both monomers, before achieving the energetically 
favorable formed complex (Kuser, Cupri, Bleicher, & Polikarpov, 2008); and iii) The 
"conformational selection" mechanism assumes that bound states are naturally samples in the 
individual proteins and the binding partner selects those conformations that are energetically 
favorable for binding (Gianni, Dogan, & Jemth, 2014). 
 
[INSERT FIGURE 3 HERE] 
  
Protein-protein docking aims to predict the structure of a protein complex, inspired on the 
association mechanisms above described. In a real case scenario, the only information available 
is the 3D structure (or a reasonable model) of the unbound proteins. Current sampling strategies 
can be classified in: exhaustive global search, local shape feature matching, and randomized 
search.  
Exhaustive global search over the protein aims to sample the entire possible space around 
a protein using as a probe another protein. In a rigid-body assumption, one needs to account for 
the translation on three axes, and the rotation on three axes, being a six degree of freedom 
problem. Exhaustive search can be achieved by using a grid to convert the surface of a protein 
into a coarse description. Then, Fast Fourier Transform (FFT) calculations (Katchalski-Katzir et 
al., 1992) can be used to reduce the computational cost by simplifying the translational and 
rotational search of the molecules. To completely search the 3D space of both proteins, one of 
the proteins (by convention the biggest one) is fixed and becomes the static molecule, while the 
other one moves in the 3D space through the FFT-based algorithm. The grid representation of the 
molecules allows to distinguish between the inside, the surface, and the outside of each protein. 
PROTEIN-PROTEIN DOCKING IN BIOMEDICINE 25 
The next step is to obtain a correlation score for all the relative translations between the two 
grids. This correlation score can be calculated on the molecular shape complementarity of the 
grids, by taking only into account the overlapping between surfaces as defined in the protein 
grids. After speeding the correlation calculation by FFT algorithms, a scoring function is applied 
and, this process repeats for each of the rotations of the mobile protein. This performs an 
exhaustive search of the 3D space of the interacting molecules. This method is by far the most 
popular one and has given rise to different programs where the differences are the description of 
the molecules on the grid. Some of these programs are FTDock (Gabb, Jackson, & Sternberg, 
1997), ZDOCK (Chen, Li, & Weng, 2003), SDOCK (C. Zhang & Lai, 2011), PIPER (Kozakov, 
Brenke, Comeau, & Vajda, 2006), MolFit (Redington, 1992). A drawback of this type of 
approach is that it considers both proteins as rigid bodies, therefore, while it is suitable for an 
initial docking approach, it does not take into account the flexibility of both proteins. In fact, 
flexibility is one of the major current challenges for all docking algorithms.  
Another approach is the local shape feature matching, with problem still remaining within 
six degrees of freedom. In this type of approach the molecular surface of both unbound proteins 
is calculated, which helps to identify binding regions. A segmentation algorithm is used to 
identify geometric features, such as convex, concave, and flat zones. Then, the molecular shape 
is represented by a graph in which each node is a representation for a surface region of the 
protein. The next step is to identify matching surfaces, with clique-search based approaches or 
geometric hashing. Programs like Patchdock (Schneidman-Duhovny, Inbar, Nussinov, & 
Wolfson, 2005), DOCK (Kuntz, Blaney, Oatley, Langridge, & Ferrin, 1982), or LZerD 
(Esquivel-Rodriguez, Filos-Gonzalez, Li, & Kihara, 2014) use this type of sampling to produce 
tens of thousands poses in a fast manner. One of the particular problems of this approach is that 
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the generated docking poses often include many atomic clashes, so additional steps of steric 
checking, clustering of solutions to avoid redundancy, or refinement are needed.  
The third approach in sampling is random search. In this case, it is important to define 
several starting points and then drive the sampling towards the optimal positions. Some methods 
such as ICM disco (Fernandez-Recio, Totrov, & Abagyan, 2003), RossetaDock and HADDOCK 
(Dominguez, Boelens, & Bonvin, 2003) use random search as part of their docking strategy. 
Other algorithms are inspired by the swarms observed in the birds or insects, such as the Particle 
Swarm Optimization (PSO) (Clerc, 2010; Krishnanand & Ghose, 2008). For exploring the 
energetic landscape, the best energetic complexes are selected, and they are subsequently used as 
new seeds, with the process iterating until there are no new seeds. During the funnel-like search, 
the process only keeps the energetically favorable conformations and drives the docking proteins 
to the optimal matching pose. This type of algorithms can consider the flexibility of the proteins 
in the final refinement phase, during the minimization, or through normal mode representation of 
the search vectors. These algorithms are very successful to find near-native solutions, but 
computationally expensive. One successful example is the program SwarmDock (Moal & Bates, 
2010).  
 
4.2.  Scoring of docking poses 
Many current protein-protein docking protocols are successful if the interacting proteins undergo 
only small conformational changes upon binding. Even in these conditions, docking algorithms 
generate a large number of incorrect docking poses, so the aim is to place the near-native 
solutions as close to the top as possible within a ranked list. An important part of the success 
depends on the accuracy of the scoring function used to evaluate the docked conformations, 
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which in turns depends on its capabilities to overcome the inaccuracies of the interacting surfaces 
and singling out near-native conformations (Halperin, Ma, Wolfson, & Nussinov, 2002; Vajda & 
Kozakov, 2009). Generally speaking, scoring aims to identify the lowest-energy state among the 
different possible states of a given interaction, and thus, in the case of docking, it should be 
ideally able to describe the energetic aspects of protein-protein association (Moal & Fernandez-
Recio, 2012). For practical predictions, the energy description of a system is estimated by 
approximate functions, and a large variety of scoring functions have been used, defined at 
different resolution levels (atomic or residue) (Tobi & Bahar, 2006). Docking algorithms often 
rely on the geometric complementarity of protein-protein interfaces. The essential zones for 
binding are often pre-formed in the interacting proteins (Levy, 2010), and as a consequence the 
interface of a protein complex could be considered an inherent geometric feature of the protein 
structures. This has made shape complementarity a popular ranking criterion to identify near-
native solutions. Still, many protein-protein interfaces are flat, so complementarity alone is not 
enough to describe the right association mode. This is one of the reasons why a sampling step 
based only on geometry criteria often fails to produce correct models. Indeed, the 
physicochemical nature of the residues has a major role in protein association. Important 
elements include the electrostatic forces with complementary charges helping to provide the 
micro environment needed for the interface formation and the correct orientation of the proteins, 
and the hydrophobic effect with the burial of hydrophobic patches favoring the desolvation of the 
interacting surfaces (Camacho & Vajda, 2001; Camacho, Weng, Vajda, & DeLisi, 1999). Other 
factors are van der Waals attraction and repulsion, and hydrogen bonding. However, scoring 
functions that use energy-based terms to model these effects are not yet accurate enough to 
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reliably select near-native solutions from a pool of decoys, and thus further investigation is 
required to improve the quality of docking predictions.  
Usually sampling and scoring are intimately coupled in a docking procedure. However, in 
many procedures, scoring is performed independently as a post-docking analysis. Basically, this 
approach consists in using a scoring function to re-rank the poses generated by a given docking 
program. This strategy could be considered as a type of refinement of the docking results, but 
using more sophisticated scoring functions than those used during the search phase. The idea 
behind post-docking approaches comes from the reasonable success of sampling algorithms to 
produce at least one near-native solution, also called a hit. In many cases, the in-built scoring 
function during the docking phase cannot be sensitive enough to place the near-native solution 
within the top of a ranked list of possible conformations. The computational problem is 
simplified by detaching the scoring functions from the sampling process, which also adds the 
possibility of combining different scoring functions. Some examples of post-docking methods 
are pyDock (Cheng, Blundell, & Fernandez-Recio, 2007), ZRANK (Pierce & Weng, 2007), 
SIPPER (Pons, Talavera, de la Cruz, Orozco, & Fernandez-Recio, 2011), DARS (Chuang et al., 
2008). Given that docking programs typically report decoys ranked with only one or two scoring 
functions, it remains to be seen whether a given method could further benefit from the 
accumulated knowledge derived from the variety of currently available scoring functions that 
have been reported in the literature, many of which were developed for different modeling 
problems (Tobi, 2010). One example of this is the combination PIE/PIER (Viswanath, Ravikant, 
& Elber, 2013). In some methods, the scoring functions are also combined with the inclusion of 
protein flexibility, like in Fiberdock (Mashiach, Nussinov, & Wolfson, 2010), Firedock 
(Andrusier, Nussinov, & Wolfson, 2007), or RDOCK (L. Li, Chen, & Weng, 2003). 
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Among the different scoring functions applied as post-docking analysis, we note the 
program pyDock (Cheng et al., 2007), which is a well-known protein-protein protocol using the 
FTDock or ZDOCK sampling combined with a highly efficient scoring function. The pyDock 
scoring function is formed by three energy-based terms: Coulombic electrostatics, desolvation 
energy and van der Waals potential. A protein is a charged entity and its surface has to be in 
constant contact with solvent molecules, so considering the electrostatic charges of the proteins 
is the basis of the majority of the scoring functions. But electrostatics alone is not enough to 
place the two interacting proteins in the optimal position, so there is a need for additional terms 
to help to improve the algorithm. Since many of the binding surfaces are flat, and the critical 
contact residues at the interface are often hydrophobic, desolvation plays a major role in creating 
the micro-environment necessary to allow the formation of a strong interaction between proteins. 
On the other side, the van der Waals energy is usually important for the final assembly of two 
given proteins, and it is very dependent on the correct side-chain conformations. When docking 
is rigid-body, this potential is very noisy. The use of all the above mentioned energy descriptors 
makes pyDock a very versatile, non-deterministic, and adaptable docking method.  
 
4.3. Template-based docking 
In addition to ab initio docking, the interface between two interacting proteins could be modeled 
using the existing structural data in the PDB (Sinha, Kundrotas, & Vakser, 2012). Figure 4 shows 
a schematic view of a template-based docking protocol in comparison with ab initio docking. As 
seen in modeling of individual proteins, some evolutionary distant PPIs converged in a structural 
conformation which is optimal for the recognition (interologs) (Matthews et al., 2001). The 
identification of interologs facilitates the study of PPIs. The conservation of the structural 
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conformation of the interface through evolution has also demonstrated a plasticity to changes, 
where only 66% of the interface patch is conserved, leaving the remaining 34% of the interface 
tolerant to residue changes (Faure, Andreani, & Guerois, 2012). However, the interface is also a 
dynamic part of the protein that can change during binding (Hamp & Rost, 2012). In fact, the 
inclusion of evolutionary data in the context of interface predictions seem to give additional 
confidence in the prediction (Hamp & Rost, 2015; Katsonis & Lichtarge, 2014). 
 
[INSERT FIGURE 4 HERE] 
 
It has been recently claimed that there could be available templates for most of the known 
protein complexes (Kundrotas, Zhu, Janin, & Vakser, 2012). However, in the case of remote 
homology, i.e. the twilight zone, the available templates do not provide better modeling than ab 
initio docking (Negroni, Mosca, & Aloy, 2014). 
 
4.4. Interface and hot-spot prediction 
The use of new approaches continues to enable the study of protein interactions from different 
perspectives. The analysis of protein-protein complex structures have aimed to identify different 
properties that can distinguish protein-protein interfaces from the rest of the protein surface 
(Jones & Thornton, 1997). The protein-protein interface is a critical zone for molecular 
recognition, formed by an average of ~28 residues, accounting for around 1000 A2 of the area in 
one protein, and mostly flat. Based on the relative Accessible Surface Area (rASA) of the 
residues in the interface, three different zones could be defined (Levy, 2010), as shown in Figure 
5: i) core, formed by residues that are exposed in the unbound monomers (rASA unbound > 
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25%) and become buried in the complex (rASA complex < 25%), forming the necessary contacts 
for the interaction and contributing largely to the binding energy; ii) rim residues, which are 
exposed in the unbound monomers (rASA unbound > 25%) and, although to a lesser extent, 
remain exposed in the complex (rASA complex > 25%), shielding the core from the solvent and 
providing the micro-environment required for establishing the interaction; and iii) support, 
formed by residues that are largely buried in the unbound monomers (rASA unbound < 25%), 
and become more buried in the complex (rASA complex < 25%), helping to establish the 
interaction.  
 
[INSERT FIGURE 5 HERE] 
 
Interface residues seem to play different roles in disease according to the region they 
belong to. In a recent study, it was found that the core interface residues are more susceptible to 
disease-related mutations, in contrast to those in the rim regions (David & Sternberg, 2015). 
Complementary work showed that about 11% of all known disease-associated SNPs also land 
outside but near to the interface (Gao, Zhou, & Skolnick, 2015). Both studies found that the 
residues that are more vulnerable to disease-related mutations are residues buried in the interface, 
although they seem to differ about the preferred localization of these mutations.  
Alanine scanning (Morrison & Weiss, 2001) can be used to experimentally describe the 
contribution of the different residues to the interaction. The technique consists in performing 
point mutations in the protein sequence for alanine, so that the chemical neutral nature and size 
of the alanine residue mimics the removal of a given residue without perturbing too much the 
secondary structure. Based on this technique, experimental analyses have shown that most of the 
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binding affinity is contributed by just a small number of interface residues, called hot-spots, 
which are often found at the interface core (Clackson & Wells, 1995). The identification of such 
hot-spot residues at protein-protein interfaces in complexes of biomedical interest is relevant for 
drug discovery purposes, as they are suitable targets for small-molecules capable of modulating 
the interaction. However, experimental determination of hot-spots by alanine scanning is costly 
and time consuming. This has fostered the development of many computational approaches that 
aim to complement experimental data. The vast majority of the predictive methods strongly rely 
on the availability of the complex structure. Several energy-based methods have been reported, 
such as ROBETTA (Kortemme & Baker, 2002), FoldX (Schymkowitz et al., 2005), HSPred 
(Lise, Buchan, Pontil, & Jones, 2011) or Molecular Dynamics (MD) with generalized Born 
model in a continuum medium (Moreira, Fernandes, & Ramos, 2007), supported in several MD 
platforms (e.g., AMBER (Salomon-Ferrer, Case, & Walker, 2013) and GROMACS (Pronk et al., 
2013)), which are based on computational alanine scanning of protein-protein interfaces and 
subsequent evaluation of the change in binding affinity.  
Other valuable approaches are based on machine learning. Recently reported methods are 
KFC2 (Zhu & Mitchell, 2011), based on interface solvation, atomic density and plasticity 
features; PCRPi (Assi, Tanaka, Rabbitts, & Fernandez-Fuentes, 2010), combining sequence 
conservation, energy score and contact number information; PPI-Pred (Bradford & Westhead, 
2005), considering surface shape and electrostatics; MINERVA, which weights atomic packing 
density and hydrophobicity (K. I. Cho, Kim, & Lee, 2009) or a neural network-based protocol 
(an adaptation of ISIS), which combines several interface features such as sequence profiles, 
solvent accessibility and evolutionary conservation (Ofran & Rost, 2007). Another well-known 
machine learning-based tool is PocketQuery web-server (Koes & Camacho, 2012), which 
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provides an assortment of metrics (including changes in solvent accessible surface area, energy-
based scores, and sequence conservation) extremely useful for hot-spots, anchor residues and hot 
regions prediction. 
Empirical formula-based methods are also used instead of machine learning algorithms, 
such as MAPPIS (Shulman-Peleg, Shatsky, Nussinov, & Wolfson, 2007), which relies on the 
evolutionary conservation of hot-spots in the interface along different family members; HotSpot 
Wizard (Pavelka, Chovancova, & Damborsky, 2009), based on the integration of structural, 
functional and evolutionary information provided by several databases; DrugScorePPI (Kruger, 
Ignacio Garzon, Chacon, & Gohlke, 2014), derived from experimental alanine scanning results; 
iPRED (Geppert, Hoy, Wessler, & Schneider, 2011), using pairwise potential atom types and 
residue properties; APIS (Xia, Zhao, Song, & Huang, 2010), where the hot-spots identification is 
performed by combining residue physical/biochemical features, such as protrusion index and 
solvent accessibility; HotPoint (Tuncbag, Keskin, & Gursoy, 2010), using occlusion from solvent 
and knowledge-based pair residue potentials; and ECMIS (Shingate, Manoharan, Sukhwal, & 
Sowdhamini, 2014), using a new algorithm combining energetic, evolutionary and structural 
features. 
In spite of their high accuracy in the identification of hot-spot residues, a major limitation 
of all the above cited tools is that they depend on the availability of the protein-protein complex 
structure (or a reliable model). However, for the majority of interactions, the complex structure is 
not available, and as a consequence these tools cannot be used. A very few hot-spot prediction 
methods have been reported that do not need the structure of the complex. One of such methods 
is pyDockNIP (Grosdidier & Fernandez-Recio, 2008), which is based on the analysis of protein-
protein docking models generated with pyDock (Cheng et al., 2007). The method computes the 
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propensity of a given residue to be located at the interface in the 100 lowest-energy rigid body 
docking solutions, and can reach high precision in the prediction of hot-spots, but at the expense 
of low sensitivity. Another method that do not need the complex structure is SIM (Agrawal, 
Helk, & Trout, 2014), which predicts hot-spot residues involved in evolutionarily conserved 
protein-protein interactions.  
All the different methods for computational analysis and prediction of interface and hot-
spot residues have inspired the creation of several databases of computationally predicted hot-
spot residues, such as HotRegion (Cukuroglu et al., 2014), HotSprint (Guney, Tuncbag, Keskin, 
& Gursoy, 2008) and PCRPi-DB (Segura & Fernandez-Fuentes, 2011). 
 
4.5. Assessment of protein-protein docking predictions 
In order to assess the predictive accuracy of a newly developed method, it would be necessary to 
have a reference set widely accepted by the community. In the case of the protein-protein 
docking field, the reference set needs to have the crystal structure of the proteins in a free state 
and that of the complexed or bound state. These structures must have a high resolution, and good 
coverage of the proteins. In addition, the protein set should to be diverse enough, so that it can 
represent as many as the known protein families as possible. The current version of the most 
widely used protein-protein docking benchmark has 231 protein complexes (Vreven et al., 2015). 
Each of those complexes has the crystal structure of the proteins in unbound form and the bound 
form. The protein docking benchmark is divided into subcategories according to the difficulty, 
based on the conformational changes that the proteins undergo from unbound to bound states. 
The most difficult category corresponds to the cases that are the most difficult to predict with 
PROTEIN-PROTEIN DOCKING IN BIOMEDICINE 35 
current protein docking algorithms, mostly due to the large conformational changes of the 
proteins.  
Other benchmarks have been reported to assess different methods for PPI modeling, like 
binding affinity changes upon mutation (Moal & Fernandez-Recio, 2012), scorer sets from 
CAPRI (Lensink & Wodak, 2014), or binding affinity data sets (Kastritis et al., 2011). There are 
other useful databases such as template libraries (DOCKGROUND (Liu, Gao, & Vakser, 2008)), 
structural datasets with similarity between sequences (3D-Complex (Levy et al., 2006)), or 
classification of the domain-domain interaction on protein complexes like SCOPPI (Winter et al., 
2006). 
Protein-protein docking programs are blindly assessed in the Critical Assessment of 
PRedicted Interactions (CAPRI) (Janin et al., 2003), which is an international scientific effort to 
boost the development of different approaches to solve the problem of protein-protein docking. 
After more than fifteen years since the first edition, the CAPRI experiment is now the source of 
standard protein-protein docking sets and quality measurements.  
 
5. Application of computational docking to biomedicine 
5.1. Interpretation of pathological mutations perturbing protein-protein interactions 
As above mentioned, it would be important to estimate the effects of a given gene variant 
at molecular level, which will contribute to understand better the phenotype related to such 
variant, e.g. pathological condition, disease predisposition, altered drug response, etc. as well as 
to rationalize therapeutic intervention, within the context of personalized medicine. For this, it is 
essential to understand the role of the protein interaction networks in a particular biological 
process, and how genetic variants such as non-synonymous single nucleotide polymorphisms 
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(nsSNPs) can affect specific protein-protein interactions (Rual et al., 2005; Wu et al., 2014). 
When a mutation has a strong effect on the folding or stability of a protein, it may disrupt all 
interactions of the mutated protein. However, if the mutation is located at a specific protein-
binding interface, it could affect only some of the interactions of the mutated protein or "edges" 
in a particular network (so called edgetic effect) (David & Sternberg, 2015; Sahni et al., 2015; 
Zanzoni, Soler-Lopez, & Aloy, 2009; Zhong et al., 2009). In each of these situations, the 
observed disorders are ultimately different, as well as their causes, consequences, and therapeutic 
options (Figure 6).  
 
[INSERT FIGURE 6 HERE] 
 
Indeed, large-scale structural analyses show that pathological mutations are enriched on 
the domains that are relevant for protein-protein interactions (Wang et al., 2012) and many 
disease-related mutations are directly involved at protein-protein interfaces (David, Razali, Wass, 
& Sternberg, 2012; David & Sternberg, 2015; Mosca et al., 2015). It has been found that 
missense mutations described in the database OMIM can cause changes in protein-protein 
binding energy (Teng, Madej, Panchenko, & Alexov, 2009). The integration of structural data in 
proteins complexes with interaction network description can help to understand the effect of 
disease-related mutations at molecular level (Fraser, Gross, & Krogan, 2013). Through a 
combination of interaction network analysis, structural data and energetic calculations, many of 
the known pathological mutations involved in cancer and/or RASopathies have been found to 
have a direct effect on the binding affinity in some of the interactions in the RAS/MAPK cascade 
(Kiel & Serrano, 2012, 2014). Moreover, this effect (together with other structural and energetics 
PROTEIN-PROTEIN DOCKING IN BIOMEDICINE 37 
effects) can provide a first general explanation for some of the differences in phenotype. More 
recently, interaction perturbation profiling of missense mutations across a broad spectrum of 
human disorders suggests that around one third of disease mutations have edgetic effects, that is, 
they only affect to specific interactions of a given protein, as opposed to structural mutations that 
can perturb simultaneously all the interactions (Sahni et al., 2015). Interestingly, mutated 
proteins with edgetic effects have been found to play central roles in the protein network (Sahni 
et al., 2015). This is a direct explanation at molecular level of how dissimilar mutations within 
the same gene may produce distinct interaction profiles and, as a consequence, different disease 
phenotypes (Sahni et al., 2015). 
Understanding the role of pathological mutations in protein-protein interactions can help 
to improve our knowledge of disease at molecular level, which could be very important for 
predicting pathogenicity in missense mutations. The functional prediction of mutations has a 
growing importance in clinical practice, especially when dealing with patient mutations that are 
not annotated or that have unclear diagnosis, prognosis or disease development. In these 
situations, general pathogenicity prediction methods are used, such as PolyPhen-2 (Adzhubei, 
Jordan, & Sunyaev, 2013; Adzhubei et al., 2010), SIFT (Sim et al., 2012), or PON-P2 (Niroula, 
Urolagin, & Vihinen, 2015), which can help physicians to make clinical decisions. These 
methods have good prediction rates in general, but they fail in many specific diseases (Riera, 
Padilla, & de la Cruz, 2016). Indeed, current models cannot correctly describe all the effects that 
amino acid mutations can cause in proteins, such as to what extent the mutation is perturbing the 
interactions to other proteins and biomolecules (Cheng et al., 2012), as above mentioned.  
Thus, for a more complete characterization of a given mutation at molecular level, with 
pathogenicity prediction purposes, it would be needed: i) to structurally characterize the location 
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of the mutation with respect to protein-binding interfaces, and ii) to characterize the energetic 
effect on the binding affinity of the involved interactions. However, one of the big limitations in 
the field is the small number of protein-protein complexes with their 3D structure deposited in 
the Protein Data Bank (PDB) (Berman et al., 2002). The structures of weak or transient 
complexes, dynamic assemblies, or multi-protein associations are particularly difficult to 
determine by crystallography or NMR, as above mentioned. As a consequence, there is a 
growing gap between the number of protein complexes with available experimental structure and 
the number of interactions that are being discovered. While around half of the non-redundant 
proteins in human have available structure (or a reliable model), less than 7% of the estimated 
number of protein-protein interactions in human have available structure (Mosca et al., 2013). In 
this context, computational docking methods (Chen et al., 2003; Cheng et al., 2007; Mashiach et 
al., 2010; C. Zhang & Lai, 2011) are already being used to model the structure of protein-protein 
complexes of biomedical interest, so in principle, they could be very useful for the structural 
characterization of entire interactomes (Mosca, Pons, Fernandez-Recio, & Aloy, 2009). However, 
for many cases, structural prediction by docking is not accurate enough, so its application at 
interactomic scale is not yet practical. More accurate is the prediction of interface residues, 
usually based on sequence conservation or physicochemical properties, which can be more 
useful for large-scale analyses. But not all the interface residues contribute equally to binding 
affinity. Thus, it is important to identify the so-called "hot-spot" residues, which are those that 
contribute the most to the binding energy (Clackson & Wells, 1995). Previous work showed that 
these interface hot-spot residues can be identified based on docking calculations, even if the 
structure of the protein-protein complex is not available (Grosdidier & Fernandez-Recio, 2008). 
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The combination of structural information and docking-based modeling will be essential for the 
interpretation of pathological mutations at interactomic level. 
 
5.2. Chemical perturbation of disease-related protein-protein interactions for drug 
discovery 
As above mentioned, pathological mutations can significantly perturb specific protein-protein 
interactions, either by disrupting these interactions or by stabilizing them (Rolland et al., 2014). 
In either case, such perturbed interactions constitute an attractive target for therapeutic 
intervention. Indeed, the identification of modulators of specific protein-protein interactions (e.g. 
PPI inhibitors) is the next milestone in the drug discovery field (Wells & McClendon, 2007). 
Several examples of PPI peptide inhibitors have been reported based on mimetic peptides that 
replace the interaction surface of one of the proteins. But the lower bioavailability of peptides 
makes them to be not very attractive for therapeutic purposes. Therefore, it is necessary to apply 
structure-based approaches to identify small molecules capable of inhibiting PPI. However, 
protein–protein interactions differ from traditional drug target proteins in that: i) protein-protein 
interfaces are large and involve more atomic interactions and hence higher affinity as compared 
to protein-ligand interfaces; ii) protein-protein interfaces do not have clear binding pockets as in 
the case of traditional protein drug targets; and iii) most often, the location of the interface and 
the binding mode of the targeted interaction is not known. All of the above considerations pose 
clear difficulties to apply standard drug discovery procedures.  
The first difficulty is that protein-protein interfaces (PPIs) are much larger (~1500-3000 
Å2) than protein-small molecule interfaces (~300-1000 Å2), which makes it difficult to find small 
molecules to disrupt PPIs. We have mentioned above the existence of hot-spot residues, which 
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are important in the context of drug discovery because targeting them is the only way for a small-
molecule to compete with a protein-protein interaction. Although there are available 
experimental data about hot-spot residues for a few complexes, it is necessary to complement the 
costly experimental procedures with computational approaches. 
The second difficulty is the absence of natural pockets in protein-protein interfaces. It is 
necessary to describe the possible fluctuations of the interacting molecules in order to find 
transient pockets that can be useful for drug discovery (Eyrisch & Helms, 2007). 
Last but not less important is the absence of structural information for the majority of 
protein-protein interactions. When there is no available structure for the complex, it is necessary 
to know at least the location of the protein-protein interface is in order to narrow the search for 
transient pockets suitable for small-molecule docking (Figure 7). 
 
[INSERT FIGURE 7 HERE] 
   
In order to help solving all the above mentioned difficulties to identify modulators of 
protein-protein interactions, computational approaches such as protein-protein docking and 
molecular dynamics are becoming increasingly important tools in drug discovery. Protein-protein 
docking aims to predict the structure of a protein-protein complex starting from the 3-D 
coordinates of the unbound structures. As mentioned in previous sections, the docking program 
pyDock (Cheng et al., 2007) can be applied to predict protein interfaces and to identify the most 
relevant residues in protein-protein interactions (hot-spots) when there is no structural 
information about the protein-protein complex (Grosdidier & Fernandez-Recio, 2008, 2012). 
Molecular dynamics (MD) is another computational approach that can be also applied to find 
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possible transient pockets within protein-protein interfaces, together with computational tools 
capable of identifying suitable cavities in the protein surfaces, such as Fpocket (Le Guilloux, 
Schmidtke, & Tuffery, 2009), QsiteFinder (Laurie & Jackson, 2005), PASS (Brady & Stouten, 
2000)  and LigSite (Hendlich, Rippmann, & Barnickel, 1997). 
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FIGURE LEGENDS 
 
Figure 1. Study of genetic variants: reductionist vs. systemic approach. A genetic variant like 
a nsSNP can modify the structure and/or dynamics of a protein at molecular level, which in turn 
can alter the interaction network of such protein. The impact in phenotype can be studied just at 
molecular level (reductionist approach) but very often the phenotypic observation is more linked 
with the effects at higher levels of organization, such as interaction network or cell scales 
(systemic approach). 
 
Figure 2. Interaction network of the proteins involved in the RAS-MAPK cascade. In red, 
proteins hosting mutations associated with cancer or RASopathies. They are part of a larger 
interaction network (generated with Interactome3D; http://interactome3d.irbbarcelona.org/), 
involving many more proteins represented here as blue circles. 
 
Figure 3. Basic scheme of a protein-protein docking method. From the coordinates of two 
interacting proteins, computational docking generates thousands of possible complex models, 
ideally containing near-native models. A scoring scheme based on energetic terms or empirical 
potentials will try to identify such correct models. 
 
Figure 4.  Comparison of ab initio and template-based docking approaches. Ab initio 
docking aims to build a protein-protein complex from the structures of the individual interacting 
proteins, using computational sampling and scoring based on energy considerations or empirical 
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parameters. In template-based docking, the protein-protein complex structure is built based on a 
template complex structure in which the components are homologous to the individual 
interacting proteins.  
 
Figure 5. Different types of zones in a protein-protein interface. In a protein-protein complex 
structure, the interface residues can be defined as those that become more buried upon binding. 
Such interface residues can be classified in: i) core, residues exposed in the unbound state and 
buried in the complex; ii) rim, residues exposed in the unbound state and slightly less exposed in 
the complex; and iii) support, residues buried in the unbound state and more buried in the 
complex. 
 
Figure 6. New advances in the interpretation of biological mutational data: from molecules 
to networks. 
Personalized medicine aims to understand the effect of genetic variants on the development and 
onset of pathological conditions and on the response to existing treatments, so that therapeutic 
intervention can be optimally selected for each patient given his genetic profile. In this context, 
disease needs to be described at all levels, from molecular to system, for which understanding 
the interaction networks involved in a given pathology is a key step. Computational methods like 
protein-protein docking are useful tools for characterizing protein-protein interfaces to localize 
pathological variants and predict its effects on binding affinity (left panel). The effect of this 
molecular perturbation on the interaction networks (edgetic effect) can lead to the development 
of more accurate personalized therapies and the developments of new drugs (right panel). 
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Figure 7. Inhibiting protein-protein interactions with small molecules. Two examples of 
protein-protein interactions that are known to be inhibited by small molecules: IL2R/IL2 
complex (left) and XIAP-Bir3/CASPASE9 complex (right). The crystallographic structures of 
the proteins bound to the corresponding small-molecule inhibitors are shown (PDB codes 1PY2 
and 1TFT, respectively), with details of the protein-inhibitor interface (cyan surface). For 
comparison, the orientation of the partner protein in the corresponding protein-protein complex 
structure is shown (orange ribbon; PDB codes 1Z92 and 1NW9, respectively). In both cases, the 
small molecule clearly overlaps with part of the protein-protein interface (blue surface), and 
therefore disrupt the interaction. Inhibitor cavities are not fully open in the unbound protein 
(bottom panel; PDB codes 1M47 and 1F9X, respectively), which makes them highly difficult to 
identify.   
 
 
 







